These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 25811429)
1. Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1. Murata M; Narahara S; Kawano T; Hamano N; Piao JS; Kang JH; Ohuchida K; Murakami T; Hashizume M Mol Pharm; 2015 May; 12(5):1422-30. PubMed ID: 25811429 [TBL] [Abstract][Full Text] [Related]
2. Ultrasensitive MRI detection of spontaneous pancreatic tumors with nanocage-based targeted contrast agent. Kawano T; Murata M; Kang JH; Piao JS; Narahara S; Hyodo F; Hamano N; Guo J; Oguri S; Ohuchida K; Hashizume M Biomaterials; 2018 Jan; 152():37-46. PubMed ID: 29107217 [TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of myristoylated preS1-conjugated nanocages for targeted cell delivery. Murata M; Piao JS; Narahara S; Kawano T; Hamano N; Kang JH; Asai D; Ugawa R; Hashizume M Protein Expr Purif; 2015 Jun; 110():52-6. PubMed ID: 25497224 [TBL] [Abstract][Full Text] [Related]
4. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation. Hu C; Huang Y; Chen Y Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418 [TBL] [Abstract][Full Text] [Related]
6. Novel engineered HER2 specific recombinant protein nanocages for targeted drug delivery. Kheshti J; Ahmadyousefi M; Soleimani M Mol Biol Rep; 2024 Jun; 51(1):773. PubMed ID: 38904710 [TBL] [Abstract][Full Text] [Related]
7. Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging. Cho HJ; Lee SJ; Park SJ; Paik CH; Lee SM; Kim S; Lee YS J Control Release; 2016 Sep; 237():177-184. PubMed ID: 27349354 [TBL] [Abstract][Full Text] [Related]
8. A Versatile Virus-Mimetic Engineering Approach for Concurrent Protein Nanocage Surface-Functionalization and Cargo Encapsulation. Sheng Y; Chen Z; Cherrier MV; Martin L; Bui TTT; Li W; Lynham S; Nicolet Y; Ebrahimi KH Small; 2024 Aug; 20(31):e2310913. PubMed ID: 38726952 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma. Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248 [TBL] [Abstract][Full Text] [Related]
10. Development of human hepatocellular carcinoma cell-targeted protein cages. Toita R; Murata M; Tabata S; Abe K; Narahara S; Piao JS; Kang JH; Hashizume M Bioconjug Chem; 2012 Jul; 23(7):1494-501. PubMed ID: 22621213 [TBL] [Abstract][Full Text] [Related]
11. Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors. Karandish F; Froberg J; Borowicz P; Wilkinson JC; Choi Y; Mallik S Colloids Surf B Biointerfaces; 2018 Mar; 163():225-235. PubMed ID: 29304437 [TBL] [Abstract][Full Text] [Related]
12. Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer. Truffi M; Fiandra L; Sorrentino L; Monieri M; Corsi F; Mazzucchelli S Pharmacol Res; 2016 May; 107():57-65. PubMed ID: 26968122 [TBL] [Abstract][Full Text] [Related]
13. Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. Bellini M; Mazzucchelli S; Galbiati E; Sommaruga S; Fiandra L; Truffi M; Rizzuto MA; Colombo M; Tortora P; Corsi F; Prosperi D J Control Release; 2014 Dec; 196():184-96. PubMed ID: 25312541 [TBL] [Abstract][Full Text] [Related]
14. EGFR Ligand Clustering on E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells. Lieser RM; Hartzell EJ; Yur D; Sullivan MO; Chen W Bioconjug Chem; 2022 Mar; 33(3):452-462. PubMed ID: 35167278 [TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment. Kumar A; Huo S; Zhang X; Liu J; Tan A; Li S; Jin S; Xue X; Zhao Y; Ji T; Han L; Liu H; Zhang X; Zhang J; Zou G; Wang T; Tang S; Liang XJ ACS Nano; 2014 May; 8(5):4205-20. PubMed ID: 24730557 [TBL] [Abstract][Full Text] [Related]
16. Engineered Hsp Protein Nanocages for siRNA Delivery. Guan X; Chang Y; Sun J; Song J; Xie Y Macromol Biosci; 2018 May; 18(5):e1800013. PubMed ID: 29665276 [TBL] [Abstract][Full Text] [Related]
17. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer. Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444 [TBL] [Abstract][Full Text] [Related]
18. iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers. Zuo H J Oncol; 2019; 2019():9367845. PubMed ID: 31346334 [TBL] [Abstract][Full Text] [Related]
19. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation. Kadonosono T; Yamano A; Goto T; Tsubaki T; Niibori M; Kuchimaru T; Kizaka-Kondoh S J Control Release; 2015 Mar; 201():14-21. PubMed ID: 25592386 [TBL] [Abstract][Full Text] [Related]
20. Increased antitumor activity of tumor-specific peptide modified thymopentin. Lao X; Li B; Liu M; Chen J; Gao X; Zheng H Biochimie; 2014 Dec; 107 Pt B():277-85. PubMed ID: 25236717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]